Ethical Holdings (Ethcy) - seriously undervalued Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ethical Holdings (Ethcy) - seriously undervalued

Public Reply Prvt Reply Mark as Last Read File

Previous 10 PreviousNext

From: Thomas Kirwin	11/12/2006 9:49:07 AM
	of 345

Ethical Holdings became Amarin Corporation in December 1999 Amarin Corporation plc is a specialty pharmaceutical company headquartered in London (UK), which focuses on the treatment of neurological disorders, especially movement disorders such as Parkinson's disease. Amarin Corporation started life as Ethical Holdings plc, a drug delivery company specializing in oral and transdermal delivery systems, Darren Cunningham, Executive Vice President Strategic Development, explained. The company became Amarin Corporation in December 1999 to reflect its move to specialty pharmaceuticals, and aims to become one of the leading neurology pharmaceutical companies. The strategy behind the change was to move away from a field dependent on milestone payments from third party companies, and towards more sustainable income based on product revenue, as well as shifting from a European to a US focus.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 PreviousNext